Table 5.
Association between maximal CD20 expression in biopsy and urine levels of chemokines adjusted for age and treatment
| Variable | N | β* | p value |
|---|---|---|---|
| CCL2 | 107 | −0.09 | 0.59 |
| CCL3 | 15 | 2.93 | 0.02* |
| CCL5 | 89 | −0.03 | 0.88 |
| CXCL1 | 105 | 0.001 | 0.99 |
| CXCL8 | 105 | 0.089 | 0.55 |
| CXCL10 | 96 | 0.014 | 0.92 |
| IL6 | 74 | 0.06 | 0.75 |
| IL1RA | 107 | 0.004 | 0.97 |
| PDGF-BB | 89 | −0.11 | 0.64 |
| sCD40L | 46 | 0.29 | 0.30 |
Urine levels of CCL3 were significantly associated with maximal CD20 expression.
*
Linear regression modelling employed CD20 as the response and the log transformed urinary chemokine as the primary covariate to calculate β coefficient adjusted for age and BPH treatment